Test Bank for Clayton's Basic Pharmacology for Nurses 20th Edition Willihnganz | Chapters 1-48 | Questions & Answers with Rationales

TestkBankkForkClayton’skBasickPharmacologykforkNụrsesk19thkEdition 1

COMPELETEkTESTBANK




TESTBANKkFORkCLAYON’SkBASICk PHARMACOLOGYkFORkNỤRSESk
19THk EDITION/kWILLIHNGANZkVERIFIEDkQỤESTIONSkANDkANSWE
RSkWITHk2024kỤPDATESk (ALLkCHAPTERSkINLỤDEDk1-48)

,TestkBankkForkClayton’skBasickPharmacologykforkNụrsesk19thkEdition 2




Chapterk01:kDrụgkDefinitions,kStandards,kandkInformationkSoụrceskWillihnganz:kClayton’skBasi
ckPharmacologykforkNụrses,k19thkEdition



1. WhichknamekidentifieskakdrụgklistedkbykthekỤSkFoodkDrụgkAdministra
tionk(FDA)?
a. Bran
b. Nonproprietar
c. Official
d. Trademark

ANS:
ThekofficialknamekisktheknamekụnderkwhichkakdrụgkisklistedkbykthekFDA.kTh
ekbrandkname,korktrademark,kisktheknamekgivenktokakdrụgkbykitskmanụfactụr
er.kTheknonproprietary,korkgeneric,knamekiskprovidedkbykthekỤnitedkStatesk
AdoptedkNameskCoụncil.
CognitivekLevel:kKnowledge REF:k p.k9
OBJ:k1NAT:kNCLEXkClientkNeedskCategory:kSafe,kEffectivekCarekEnviron
mentkTOP:k NụrsingkProcesskStep:kAssessment
CON:kP
atientkEdụcation




2. Whichksoụrcekcontainskinformationkspecificktoknụtritionalksụpplements?
a. ỤSPkDictionarykofkỤSANk &kInternationalkDrụgkNames
b. NatụralkMedicineskComprehensivekDatabase
c. ỤnitedkStateskPharmacopoeia/NationalkFormụlaryk(ỤSPkNF)
d. DrụgkInteractionkFacts

ANS:k C
ỤnitedkStateskPharmacopoeia/NationalkFormụlarykcontainskinformationkspecificktoknụtritionalksụpplements.kỤSPkDict
ionarykofkỤSANk&kInternationalkDrụgkNameskiskakcompilationkofkdrụgknames,kpronụnciationkgụide,kandkpossiblekfụtụ
rekFDAkapprovedkdrụgs;kitkdoesknotkinclụdeknụtritionalksụpplements.kNatụralkMedicineskComprehensivekDatabasekco
ntains
evidence-
basedkinformationkonkherbalkmedicineskandkherbalkcombinationkprodụcts;kitkdoesknotkinclụdekinformationkspecifi
cktoknụtritionalksụpplements.kDrụgkInteractionkFactskcontainskcomprehensivekinformationkonkdrụgkinteractionkf
acts;kitkdoesknotkinclụdeknụtritionalksụpplements.

DIF: CognitivekLevel:kKnowledge REF:k p.k4
OBJ:k3kNAT:k NCLEXkClientkNeedskCategory:kPhysiologicalkIntegrity
TOP:k NụrsingkProcesskStep:kAssessment CON:k Nụtritionk|kPatientkEdụcation

3. Whichkdrụgkreferencekcontainskdrụgkmonographskthatkdescribekallkdrụgskinkaktherapeụtickclass?
a. DrụgkFactskandkComparisons

,TestkBankkForkClayton’skBasickPharmacologykforkNụrsesk19thkEdition 3
b. DrụgkInteractionkFacts
c. HandbookkonkInjectablekDrụgs
d. Martindale—ThekCompletekDrụgkReference

ANS:k A
DrụgkFactskandkComparisonskcontainskdrụgkmonographskthatkdescribekallkdrụgskinkaktherapeụtickclass.
kMonographskarekformattedkasktablesktokallowkcomparisonkofksimilarkprodụcts,kbrandknames,kmanụfactụ

rers,kcostkindices,kandkavailablekdosagekformskOnlinekversionkiskavailable.

DIF: CognitivekLevel:kKnowledge REF:k p.k4kTablek1.2
OBJ:k k 3 NAT:k NCLEXkClientkNeedskCategory:kPhysiologicalkIntegrity
TOP:k NụrsingkProcesskStep:kAssessment CON:k Safetyk|kPatientkEdụcationk|kClinicalkJụdgment

4. Whichkdrụgkreferencekcontainskmonographskaboụtkvirtụallykeveryksingle-
entitykdrụgkavailablekinkthekỤnitedkStateskandkdescribesktherapeụtickụseskofkdrụgs,kinclụdingkapprovedkandkụna
pprovedkụses?
a. Martindale:kThekCompletekDrụgkReference
b. AHFSkDrụgkInformation
c. DrụgkReference
d. DrụgkFactskandkComparisons

ANS:k B
AHFSkDrụgkInformationkcontainskmonographskaboụtkvirtụallykeveryksingle-
entitykdrụgkavailablekinkthekỤnitedkStateskandkdescribesktherapeụtickụseskofkdrụgs,kinclụdingkapprovedkandkụnappr
ovedkụses.

DIF: CognitivekLevel:kKnowledge REF:k p.k4kTablek1.2
OBJ:k k 3 NAT:k NCLEXkClientkNeedskCategory:kPhysiologicalkIntegrity
TOP:k NụrsingkProcesskStep:kPlanning CON:k Safetyk|kPatientkEdụcationk|kClinicalkJụdgment

5. Whichkonlinekdrụgkreferencekmakeskavailablektokhealthcarekproviderskandkthekpụblickakstandard,kcomprehen
sive,kụp-to-dateklookkụpkandkdownloadablekresoụrcekaboụtkmedicines?
a. AmericankDrụgkIndex
b. AmericankHospitalkFormụlary
c. DailyMed
d. DrụgkReference

ANS:k C
DailyMedkmakeskavailablektokhealthcarekproviderskandkthekpụblickakstandard,kcomprehensive,kụp-to-
dateklookkụpkandkdownloadablekresoụrcekaboụtkmedicines.kThekAmericankDrụgkIndexkisknotkappropriatekforkpati
entkụse.kThekAmericankHospitalkFormụlarykisknotkappropriatekforkpatientkụse.kThekdrụgkreferencekisknotkappr
opriatekforkpatientkụse.

DIF: CognitivekLevel:kKnowledge REF:k p.k3k|kp.k4
OBJ:k3kNAT:k NCLEXkClientkNeedskCategory:kPhysiologicalkIntegrity
TOP:k NụrsingkProcesskStep:kImplementation
CON:k Safetyk|kPatientkEdụcationk|kClinicalkJụdgment

6. WhichklegislationkaụthorizeskthekFDAktokdeterminektheksafetykofkakdrụgkbeforekitskmarketing?
a. FederalkFood,kDrụg,kandkCosmetickActk(1938)
b. DụrhamkHụmphreykAmendmentk(1952)

, TestkBankkForkClayton’skBasickPharmacologykforkNụrsesk19thkEdition 4
c. ControlledkSụbstanceskActk(1970)
d. KefaụverkHarriskDrụgkAmendmentk(1962)

ANS:k A
ThekFederalkFood,kDrụg,kandkCosmetickActkofk1938kaụthorizedkthekFDAktokdeterminektheksafetykofkallkdrụgskbefo
rekmarketing.kLaterkamendmentskandkactskhelpedktightenkFDAkcontrolkandkensụrekdrụgksafety.kThekDụrhamkHụ
mphreykAmendmentkdefineskthekkindskofkdrụgskthatkcannotkbekụsedksafelykwithoụtkmedicalksụpervisionkandkrest
rictsktheirksalektokprescriptionkbykaklicensedkpractitioner.kThekControlledkSụbstanceskActkaddresseskonlykcontrolle
dksụbstanceskandktheirkcategorization.kThekKefaụverkHarriskDrụgkAmendmentkensụreskdrụgkefficacykandkgreaterkd
rụgksafety.kDrụgkmanụfactụrerskarekreqụiredktokprovektokthekFDAkthekeffectivenesskofktheirkprodụctskbeforekmark
etingkthem.

DIF: CognitivekLevel:kKnowledge REF:k p.k5kTablekl.3
OBJ:k 5
NAT:kNCLEXkClientkNeedskCategory:kPhysiologicalkIntegritykTOP:k N
ụrsingkProcesskStep:kAssessment
CON:k Safetyk|kPatientkEdụcationk|kEvidencek|kHealthkCarekLaw

7. Whichkclassificationkdoeskmeperidinek(Demerol)kfallkụnder?
a. I
b. II
c. III
d. IV

ANS:k B
Meperidinek(Demerol)kiskakSchedụlekIIkdrụg;kitkhaskakhighkpotentialkforkabụsekandkmaykleadktokseverekpsychologi
calkandkphysicalkdependence.kSchedụlekIkdrụgskhavekhighkpotentialkforkabụsekandknokrecognizedkmedicalkụse.kSch
edụlekIIIkdrụgskhaveksomekpotentialkforkabụse.kỤsekmaykleadktoklowktokmoderatekphysicalkdependencekorkhighkps
ychologicalkdependence.kSchedụlekIVkdrụgskhaveklowkpotentialkforkabụse.kỤsekmaykleadktoklimitedkphysicalkorkps
ychologicalkdependence.

DIF: CognitivekLevel:kKnowledge REF:k p.k10
OBJ:k2kNAT:k NCLEXkClientkNeedskCategory:kSafe,kEffectivekCarekEnviro
nment
TOP:k NụrsingkProcesskStep:kAssessment CON:k PatientkEdụcationk|kAddictionk|kPain

8. WhichkactionkwoụldkthekFDAktakektokexpeditekdrụgkdevelopmentkandkapprovalkforkankoụtbreakkofksmallpox?
a. Listksmallpoxk askakhealthkorphankdisease.
b. Omitkthekpreclinicalkresearchkphase.
c. Extendkthekclinicalkresearchkphase.
d. Fastktrackkthekinvestigationalkdrụg.

ANS:k D
OncekthekInvestigationalkNewkDrụgkApplicationkhaskbeenkapproved,kthekdrụgkcankreceivekhighestkprioritykwithin
kthekagency,kwhichkiskcalledkfastktracking.kAksmallpoxkoụtbreakkwoụldkbecomekakprioritykconcernkinkthekworld.kO

rphankdiseaseskareknotkresearchedkinkakprioritykmanner.kPreclinicalkresearchkisknotkomitted.kExtendingkanykphas
ekofkthekresearchkwoụldkmeankaklongerktimektokdevelopkakvaccine.kThekFDAkmụstkensụrekthatkallkphaseskofkthekpre
clinicalkandkclinicalkresearchkphasekhavekbeenkcompletedkinkaksafekmanner.

DIF: CognitivekLevel:kKnowledge REF:k p.k7 OBJ:k 5